SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-7.37%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$198M
AUM Growth
+$198M
(-21%)
Cap. Flow
-$31M
Cap. Flow
% of AUM
-15.65%
Top 10 Holdings %
Top 10 Hldgs %
42%
Holding
45
New
2
Increased
14
Reduced
10
Closed
11
Top Buys
| 1 |
DexCom
DXCM
|
$4.67M |
| 2 |
HCA Healthcare
HCA
|
$3.69M |
| 3 |
Novo Nordisk
NVO
|
$3.64M |
| 4 |
Insulet
PODD
|
$3.19M |
| 5 |
UnitedHealth
UNH
|
$2.52M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$11M |
| 2 |
Becton Dickinson
BDX
|
$7.92M |
| 3 |
Elevance Health
ELV
|
$6.66M |
| 4 |
Abbott
ABT
|
$6.54M |
| 5 |
Merck
MRK
|
$5.77M |
Sector Composition
| 1 | Healthcare | 96.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
HCA Healthcare
HCA
$94.5B
| $9.84M | 4.97% |
40,000
+15,000
| +60% | +$3.69M |
|
2
Tenet Healthcare
THC
$16.3B
| $9.23M | 4.66% |
140,000
| – | – |
|
3
Humana
HUM
$36.5B
| $8.51M | 4.3% |
17,500
| – | – |
|
4
Boston Scientific
BSX
$156B
| $8.45M | 4.27% |
160,000
| – | – |
|
|
5
Novo Nordisk
NVO
$251B
| $8.19M | 4.14% |
90,000
+40,000
| +80% | +$3.64M |
|
6
Universal Health Services
UHS
$11.6B
| $8.17M | 4.13% |
65,000
+12,500
| +24% | +$1.57M |
|
7
Eli Lilly
LLY
$657B
| $8.06M | 4.07% |
15,000
-2,500
| -14% | -$1.34M |
|
8
McKesson
MCK
$85.4B
| $7.61M | 3.85% |
17,500
| – | – |
|
|
9
UnitedHealth
UNH
$281B
| $7.56M | 3.82% |
15,000
+5,000
| +50% | +$2.52M |
|
10
Stryker
SYK
$150B
| $7.52M | 3.8% |
27,500
+2,500
| +10% | +$683K |
|
|
11
SPDR S&P Biotech ETF
XBI
$5.07B
| $7.3M | 3.69% |
100,000
-150,000
| -60% | -$11M |
|
12
Cigna
CI
$80.3B
| $7.15M | 3.61% |
25,000
+5,000
| +25% | +$1.43M |
|
13
Danaher
DHR
$147B
| $6.82M | 3.45% |
27,500
+2,500
| +10% | +$620K |
|
14
Intuitive Surgical
ISRG
$170B
| $6.58M | 3.32% |
22,500
| – | – |
|
15
Cencora
COR
$56.5B
| $6.3M | 3.18% |
35,000
-5,000
| -13% | -$900K |
|
16
Medtronic
MDT
$119B
| $6.27M | 3.17% |
80,000
+20,000
| +33% | +$1.57M |
|
17
Encompass Health
EHC
$12.3B
| $6.04M | 3.05% |
90,000
-9,976
| -10% | -$670K |
|
18
Zimmer Biomet
ZBH
$21B
| $5.61M | 2.84% |
50,000
-5,000
| -9% | -$561K |
|
19
Thermo Fisher Scientific
TMO
$186B
| $5.32M | 2.69% |
10,500
+3,000
| +40% | +$1.52M |
|
20
Acadia Healthcare
ACHC
$2.12B
| $5.27M | 2.66% |
75,000
+15,000
| +25% | +$1.05M |
|
21
Cardinal Health
CAH
$35.5B
| $5.21M | 2.63% |
60,000
-25,000
| -29% | -$2.17M |
|
22
Surgery Partners
SGRY
$2.91B
| $5.12M | 2.59% |
175,000
| – | – |
|
23
Select Medical
SEM
$1.61B
| $4.86M | 2.46% |
192,343
+2,343
| +1% | +$59.2K |
|
24
Baxter International
BAX
$12.7B
| $4.72M | 2.38% |
125,000
-35,000
| -22% | -$1.32M |
|
|
25
DexCom
DXCM
$29.5B
| $4.67M | 2.36% |
+50,000
| New | +$4.67M |
|